199 related articles for article (PubMed ID: 31163193)
1. Parametric investigation of static and dynamic cell culture conditions and their impact on hCMEC/D3 barrier properties.
Hinkel S; Mattern K; Dietzel A; Reichl S; Müller-Goymann CC
Int J Pharm; 2019 Jul; 566():434-444. PubMed ID: 31163193
[TBL] [Abstract][Full Text] [Related]
2. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies.
Eigenmann DE; Xue G; Kim KS; Moses AV; Hamburger M; Oufir M
Fluids Barriers CNS; 2013 Nov; 10(1):33. PubMed ID: 24262108
[TBL] [Abstract][Full Text] [Related]
4. Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells.
Page S; Munsell A; Al-Ahmad AJ
Fluids Barriers CNS; 2016 Oct; 13(1):16. PubMed ID: 27724968
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood-Brain Barrier.
Ito S; Yanai M; Yamaguchi S; Couraud PO; Ohtsuki S
J Pharm Sci; 2017 Sep; 106(9):2599-2605. PubMed ID: 28456720
[TBL] [Abstract][Full Text] [Related]
6. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
[TBL] [Abstract][Full Text] [Related]
7. Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood-brain barrier.
Biemans EALM; Jäkel L; de Waal RMW; Kuiperij HB; Verbeek MM
J Neurosci Res; 2017 Jul; 95(7):1513-1522. PubMed ID: 27726164
[TBL] [Abstract][Full Text] [Related]
8. Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.
Masuda T; Hoshiyama T; Uemura T; Hirayama-Kurogi M; Ogata S; Furukawa A; Couraud PO; Furihata T; Ito S; Ohtsuki S
Mol Pharm; 2019 May; 16(5):2162-2171. PubMed ID: 30983357
[TBL] [Abstract][Full Text] [Related]
9. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells.
Qi D; Lin H; Hu B; Wei Y
J Control Release; 2023 Jun; 358():78-97. PubMed ID: 37076016
[TBL] [Abstract][Full Text] [Related]
10. Co-culture model consisting of human brain microvascular endothelial and peripheral blood mononuclear cells.
Strazza M; Maubert ME; Pirrone V; Wigdahl B; Nonnemacher MR
J Neurosci Methods; 2016 Aug; 269():39-45. PubMed ID: 27216631
[TBL] [Abstract][Full Text] [Related]
11. Chlorpyrifos, permethrin and cyfluthrin effect on cell survival, permeability, and tight junction in an in-vitro model of the human blood-brain barrier (BBB).
Deepika D; Kumar S; Bravo N; Esplugas R; Capodiferro M; Sharma RP; Schuhmacher M; Grimalt JO; Blanco J; Kumar V
Neurotoxicology; 2022 Dec; 93():152-162. PubMed ID: 36167171
[TBL] [Abstract][Full Text] [Related]
12. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
13. Identification of neuronal and angiogenic growth factors in an in vitro blood-brain barrier model system: Relevance in barrier integrity and tight junction formation and complexity.
Freese C; Hanada S; Fallier-Becker P; Kirkpatrick CJ; Unger RE
Microvasc Res; 2017 May; 111():1-11. PubMed ID: 27988246
[TBL] [Abstract][Full Text] [Related]
14. Studies of blood-brain barrier permeability of gastrodigenin in vitro and in vivo.
Mi Y; Mao Y; Cheng H; Ke G; Liu M; Fang C; Wang Q
Fitoterapia; 2020 Jan; 140():104447. PubMed ID: 31805306
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol strengthens barrier integrity in brain endothelial cells.
Horai S; Nakagawa S; Tanaka K; Morofuji Y; Couraud PO; Deli MA; Ozawa M; Niwa M
Cell Mol Neurobiol; 2013 Mar; 33(2):291-307. PubMed ID: 23224787
[TBL] [Abstract][Full Text] [Related]
16. The pivotal role of micro-environmental cells in a human blood-brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis.
Gerhartl A; Pracser N; Vladetic A; Hendrikx S; Friedl HP; Neuhaus W
Fluids Barriers CNS; 2020 Mar; 17(1):19. PubMed ID: 32138745
[TBL] [Abstract][Full Text] [Related]
17. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
18. Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study.
Zhang Z; McGoron AJ; Crumpler ET; Li CZ
Appl Biochem Biotechnol; 2011 Jan; 163(2):278-95. PubMed ID: 20652765
[TBL] [Abstract][Full Text] [Related]
19. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
20. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3.
Fasler-Kan E; Suenderhauf C; Barteneva N; Poller B; Gygax D; Huwyler J
Brain Res; 2010 Oct; 1354():15-22. PubMed ID: 20692239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
